CO-MORBIDITY

Clinical trials for CO-MORBIDITY explained in plain language.

Never miss a new study

Get alerted when new CO-MORBIDITY trials appear

Sign up with your email to follow new studies for CO-MORBIDITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gentler myeloma treatment shows promise for frail patients

Disease control Ongoing

This study tests a combination of three drugs—isatuximab, pomalidomide, and dexamethasone—at lower doses than usual. It includes 6 patients with multiple myeloma that has returned or not responded to treatment, who are also vulnerable due to age or other health problems. The goal…

Matched conditions: CO-MORBIDITY

Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

CO-MORBIDITY

Get alerted when new CO-MORBIDITY trials appear

Gentler myeloma treatment shows promise for frail patients